Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Beclomethasone in Preschool Children With Recurrent Wheezing
NCT02381158Phase 4Completed
- Sponsor
- CNR-Institute for Biomedical Research and Innovation
- Start
- Feb 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of beclomethasone dipropionate in wheeze, sponsored by CNR-Institute for Biomedical Research and Innovation. Primary endpoint: Lung function with Rint and FOT at 12 weeks. Started Feb 2015; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
wheeze
Beyond the preview
Go deeper on NCT02381158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02381158.